Results 261 to 270 of about 28,985 (310)
Some of the next articles are maybe not open access.

Dermatological pharmacology: systemic agents

Medicine, 2004
Abstract Systemic therapy is indicated for the treatment of skin disorders when the extent or severity of the disease would make topical therapy impractical or insufficiently effective, or because the drug used is not active when topically administered.
openaire   +1 more source

Psychoactive Agents in Dermatology

2000
In dermatology, almost all diseases can benefit from use of psychoactive drugs, but, in our opinion, psychotropic agents are more commonly useful in: 1. Psychiatric syndromes with dermatological expression; in particular: Delusion of parasitosis Dermatitis artefacta Neurotic excoriations Trichotillomania Glossodynia ...
G. Hautmann, E. Panconesi
openaire   +1 more source

DERMATOLOGIC SIDE EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS

Dermatologic Clinics, 1996
Exanthematous eruptions, urticaria, photosensitivity, pigmentary problems, acne, alopecia, fixed drug eruptions, and lichenoid reactions are the most common dermatologic side effects associated with the administration of psychopharmacologic agents. The cutaneous findings associated with the various eruptions and the most common inciting psychiatric ...
openaire   +2 more sources

Targeted Agents: Management of Dermatologic Toxicities

Journal of the National Comprehensive Cancer Network, 2014
Epidermal growth factor receptor (EGFR) inhibitors are widely used in the treatment of many cancers, and the cutaneous toxicity profile associated with these agents has become prominent. In fact, dermatologic side effects have also been reported with other targeted agents, including both BRAF and mTOR inhibitors.
openaire   +2 more sources

Keratinolytic Agents in Dermatology

1990
Keratin is an essential constituent of the keratin laminae which, together with the intercellular substances in the skin, form the stratum corneum with its barrier function and give the hair and nails their physical properties.
openaire   +1 more source

New Therapeutic Agents in Veterinary Dermatology

Veterinary Clinics of North America: Small Animal Practice, 1990
The rapid development of therapeutic agents will continue to provide veterinarians with new options in treating dermatologic disease. However, we must not overlook the possibility of new applications for older drugs. Ideally, before a drug can be recommended for routine use, it should be evaluated for safety and efficacy using unbiased scientific ...
openaire   +2 more sources

Chapter 20 Dermatological Agents

1987
Publisher Summary The field of dermatology encompasses biology, pharmacology, and pathophysiology, and is aimed at the development of more sophisticated and more effective therapies for diseases of the skin. This chapter discusses the previous review in this series, focusing on the newly developed treatments for acne, psoriasis, acute skin ...
openaire   +1 more source

Biological Agents in Pediatric Dermatology

2017
Biological agents are revolutionizing the treatment of immune-mediated disease across many disciplines, including rheumatology, gastroenterology, and dermatology. For children with psoriasis, these medications represent a welcome alternative to broad immunosuppressants such as methotrexate and cyclosporine when topical therapies are inadequate.
Emily B. Lund, Amy S. Paller
openaire   +1 more source

Antibacterial Agents in Dermatology

2000
The contemporary dermatologist quite often confronts bacterial skin and/or soft tissue infections. Therefore he should be familiar with antibacterial agents, particularly with newer antibiotics and their role in modern chemotherapy. Classification of cutaneous infections on morphologic and clinical criteria are helpful in providing initial clues ...
openaire   +1 more source

Home - About - Disclaimer - Privacy